Evan Unger
Fondateur chez Nuvox Pharma LLC
Profil
Evan C.
Unger is the founder of Nuvox Pharma LLC, NuvOx Therapeutics, Inc. He previously worked as a Director at ImaRx Therapeutics, Inc. He received his undergraduate degree from the University of California, Berkeley and his doctorate from The University of California, San Francisco.
Postes actifs de Evan Unger
| Sociétés | Poste | Début |
|---|---|---|
Nuvox Pharma LLC
 Nuvox Pharma LLC Miscellaneous Commercial ServicesCommercial Services Nuvox Pharma LLC operates as biotechnology company. Its publication includes acute hypoxemic respiratory failure, hermorrrhagic shock, mechanism of action, myorcardial infarction, oncology, pharmacokinetics, stroke, and traumatic brain injury. The company was founded by Evan Unger and is headquartered in Tucson, AZ. | Fondateur | - |
NuvOx Therapeutics, Inc.
 NuvOx Therapeutics, Inc. BiotechnologyHealth Technology NuvOx Therapeutics, Inc. is a clinical stage biotechnology company that develops oxygen therapeutics. The company is based in Tucson, AZ. NuvOx Therapeutics was founded by Jennifer Johnson, Evan C. Unger. Evan C. Unger has been the CEO since incorporation. | Fondateur | - |
Anciens postes connus de Evan Unger
| Sociétés | Poste | Fin |
|---|---|---|
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Directeur/Membre du Conseil | - |
Formation de Evan Unger
| University of California, Berkeley | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
Nuvox Pharma LLC
Nuvox Pharma LLC Miscellaneous Commercial ServicesCommercial Services Nuvox Pharma LLC operates as biotechnology company. Its publication includes acute hypoxemic respiratory failure, hermorrrhagic shock, mechanism of action, myorcardial infarction, oncology, pharmacokinetics, stroke, and traumatic brain injury. The company was founded by Evan Unger and is headquartered in Tucson, AZ. | Commercial Services |
NuvOx Therapeutics, Inc.
NuvOx Therapeutics, Inc. BiotechnologyHealth Technology NuvOx Therapeutics, Inc. is a clinical stage biotechnology company that develops oxygen therapeutics. The company is based in Tucson, AZ. NuvOx Therapeutics was founded by Jennifer Johnson, Evan C. Unger. Evan C. Unger has been the CEO since incorporation. | Health Technology |
